A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
作者信息
Beksac Meral, Seval Guldane Cengiz, Kanellias Nicholas, Coriu Daniel, Rosiñol Laura, Ozet Gulsum, Goranova-Marinova Vesselina, Unal Ali, Bila Jelena, Ozsan Hayri, Ivanaj Arben, Balić Lejla Ibricevic, Kastritis Efstathios, Bladé Joan, Dimopoulos Meletios Athanasios
机构信息
Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey.
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
出版信息
Haematologica. 2021 Apr 1;106(4):1228. doi: 10.3324/haematol.2020.278272.
Abstract
摘要
相似文献
1
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
Haematologica. 2021 Apr 1;106(4):1228. doi: 10.3324/haematol.2020.278272.
2
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
Haematologica. 2020 Jan;105(1):201-208. doi: 10.3324/haematol.2019.219295. Epub 2019 Jul 5.
3
Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.
Clin Nucl Med. 2016 Jan;41(1):e7-13. doi: 10.1097/RLU.0000000000000902.
4
Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic data.
J Ultrasound Med. 2013 Oct;32(10):1777-88. doi: 10.7863/ultra.32.10.1777.
5
Histopathologic, immunohistochemical, and cytologic analysis of feline myeloma-related disorders: further evidence for primary extramedullary development in the cat.
Vet Pathol. 2008 Mar;45(2):159-73. doi: 10.1354/vp.45-2-159.
6
[Expression of CD56 in Multiple Myeloma Cells and Its Relationship with Extramedullary Disease and Extramedullary Relapse].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):553-556. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.039.
7
Cytogenetics of extramedullary manifestations in multiple myeloma.
Br J Haematol. 2013 Apr;161(1):87-94. doi: 10.1111/bjh.12223. Epub 2013 Feb 1.
8
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
PLoS One. 2015 Sep 21;10(9):e0137294. doi: 10.1371/journal.pone.0137294. eCollection 2015.
9
MRI features of extramedullary myeloma.
AJR Am J Roentgenol. 2014 Apr;202(4):803-10. doi: 10.2214/AJR.13.10856.
10
Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):288-93. doi: 10.5507/bp.2015.014. Epub 2015 Apr 16.
引用本文的文献
1
[Consensus for the diagnosis and management of extramedullary plasmacytoma in China(2024)].
Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):8-17. doi: 10.3760/cma.j.cn121090-20231107-00253.
2
Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease.
Ann Med. 2023;55(2):2281657. doi: 10.1080/07853890.2023.2281657. Epub 2023 Dec 12.
3
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
J Hematol Oncol. 2022 Oct 23;15(1):150. doi: 10.1186/s13045-022-01374-5.
4
Extramedullary disease in multiple myeloma: a systematic literature review.
Blood Cancer J. 2022 Mar 21;12(3):45. doi: 10.1038/s41408-022-00643-3.
Zotero 插件